Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 597
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01599520 | Stress Management Training for Latinas Receiving Chemotherapy | ||
| NCT06350318 | Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas | ||
| NCT02403310 | A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML | ||
| NCT05054218 | COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients | ||
| NCT02155088 | BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer | ||
| NCT01434550 | Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer | ||
| NCT02218164 | Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma | ||
| NCT03628209 | Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma | ||
| NCT06835387 | Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors | ||
| NCT00444015 | Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) | ||
| NCT01302626 | Radiomics: a Study of Outcome in Lung Cancer | ||
| NCT01951976 | Yoga for Aromatase Inhibitor-associated Joint Pain | ||
| NCT01352000 | Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline") | ||
| NCT00592865 | Risk Factors for Adult-Onset Brain Tumors | ||
| NCT00006369 | ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer | ||
| NCT05301283 | Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma | ||
| NCT00006373 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | ||
| NCT04598724 | Addressing Barriers to Palliative Care Use in Bladder Cancer | ||
| NCT05768347 | Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC | ||
| NCT03598309 | Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers | ||
| NCT01760499 | Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study | ||
| NCT05083416 | Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome | ||
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | ||
| NCT06423950 | Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB) | ||
| NCT01286038 | Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia | ||
| NCT02652455 | Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma | ||
| NCT01416909 | Managing Medication-induced Constipation in Cancer: A Clinical Trial | ||
| NCT00802932 | Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx | ||
| NCT00005613 | Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | ||
| NCT04163718 | TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL) | ||
| NCT00226577 | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. | ||
| NCT06909357 | Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients | ||
| NCT02708381 | Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ Database | ||
| NCT05325632 | Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab | ||
| NCT05649969 | STRONG Program for Cancer Patients | ||
| NCT02945800 | Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma | ||
| NCT06855212 | Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC | ||
| NCT00948922 | Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | ||
| NCT00637689 | Improving Outcomes Assessment in Chronic GVHD | ||
| NCT01581307 | Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets | ||
| NCT03851133 | Florida Pancreas Collaborative Next Generation Biobank | ||
| NCT00597038 | A Phase I/II Study of Dasatinib and Dacarbazine | ||
| NCT07352943 | Development of a Mindfulness-Based Smartphone Application for BMT Caregivers | ||
| NCT03874325 | Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer | ||
| NCT02363491 | A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome | ||
| NCT00363467 | Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation | ||
| NCT01483664 | Communication Skills Intervention to Promote Transition Into Survivorship | ||
| NCT00005800 | Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer | ||
| NCT01054144 | Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma | ||
| NCT01886287 | P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome |
